BioConsortia Receives U.S. EPA Registration for Amara Biofungicide
AgriBusiness Global
2024.10.08
BioConsortia’s new biofungicide/bactericide, Amara has received registration from the Environmental Protection Agency (EPA). With potential applications in high-value fruit and vegetable production, the product is designed to protect crops from foliar diseases with a biological mode of action that offers an alternative to chemical fungicides and with a greater consistency in efficacy than current biological products on the market.
This consistency is achieved by Amara’s high concentration of environmentally stable active ingredient. The beneficial bacteria in Amara produce antimicrobial components that directly degrade fungal pathogen cells and promote systemic resistance within the plant, resulting in contact control and suppression of disease organisms that reduce yield.
“The EPA approval of Amara biofungicide marks a major step for BioConsortia in the use of the company’s natural biologicals to help plants fight disease,” said Marcus Meadows-Smith, Chief Executive Officer at BioConsortia. “The patented strain in Amara fungicide was discovered using our powerful biologicals discovery platform, AMS, that has been leveraged to develop a diverse pipeline of multiple leads to be commercialized through partners as products that combat disease, insects and nematodes, as well as for biostimulants and biofertilizers.”
Amara biofungicide will be marketed and sold by Nichino America, Inc. Product launch plans are currently under development, and Nichino expects for the product to be available for the 2025 use season.
BioConsortia’s new biofungicide/bactericide, Amara has received registration from the Environmental Protection Agency (EPA). With potential applications in high-value fruit and vegetable production, the product is designed to protect crops from foliar diseases with a biological mode of action that offers an alternative to chemical fungicides and with a greater consistency in efficacy than current biological products on the market.
This consistency is achieved by Amara’s high concentration of environmentally stable active ingredient. The beneficial bacteria in Amara produce antimicrobial components that directly degrade fungal pathogen cells and promote systemic resistance within the plant, resulting in contact control and suppression of disease organisms that reduce yield.
“The EPA approval of Amara biofungicide marks a major step for BioConsortia in the use of the company’s natural biologicals to help plants fight disease,” said Marcus Meadows-Smith, Chief Executive Officer at BioConsortia. “The patented strain in Amara fungicide was discovered using our powerful biologicals discovery platform, AMS, that has been leveraged to develop a diverse pipeline of multiple leads to be commercialized through partners as products that combat disease, insects and nematodes, as well as for biostimulants and biofertilizers.”
Amara biofungicide will be marketed and sold by Nichino America, Inc. Product launch plans are currently under development, and Nichino expects for the product to be available for the 2025 use season.
Read more here